Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz

Trial Profile

Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2016

At a glance

  • Drugs Efavirenz (Primary) ; Etonogestrel
  • Indications HIV infections; Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Oct 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2017.
    • 31 Oct 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 12 May 2014 Planned initiation date changed from 1 Dec 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top